LTCPA Policy Statements
| LTCPA Response to Senate Finance Committee's Modified Mark of the America's Healthy Future Act of 2009 | |
| Before requiring PDPs to implement potentially costly utilization techniques, LTCPA strongly urges the Committee to commission a study of the incidence of prescription drug waste in the outpatient setting. | |
| Read the Response (PDF) (PDF) | |
| LTC Pharmacist Testifies Before Energy & Commerce Subcommittee | |
| Larry Galluzzo, President of Skilled Care LTC pharmacy, testified before the House Energy & Commerce Health Subcommittee on a number of issues including immediate access to coverage for new LTC Part D beneficiaries, assisting LTC residents with plan selection, and recovering unpaid copays. | |
| Read the Testimony (PDF) | |
| Long Term Care Pharmacy Industry to Discuss Rebate Disclosure | |
| On November 28, 2005 the Centers for Medicare and Medicaid Services ("CMS") posted to the "Questions & Answers" portion of its web site a statement to the effect that it has concerns about the continued payment of certain rebates by pharmaceutical manufacturers to long-term care pharmacies with respect to prescriptions dispensed under the Medicare Part D prescription drug benefit. In response to this statement, the Long Term Care Pharmacy Alliance (LTCPA) issued the following statement: | |
| Read the Statement (PDF) | |
| LTCPA Statement on the Medicare Prescription Drug Legislation | |
| (December 2, 2003) -- The United States Congress has passed historic legislation establishing a prescription drug benefit for Medicare beneficiaries. This legislation now awaits the president's signature. Unlike previous versions of Medicare legislation that have been considered by Congress, this legislation takes a major step toward recognizing the needs of residents of nursing facilities; the oldest and frailest of all Medicare beneficiaries. | |
| Read Our Statement (PDF) | |
| LTCPA Issues Statement on Maine Rx Program and Medicaid Prior-Authorization Requirements | |
| (January 22, 2003) -- In recognition of today's oral arguments before the U.S. Supreme Court in PhRMA v. Concannon, the Long Term Care Pharmacy Alliance (LTCPA) issued the following statement, "LTCPA filed a friend-of-the-court brief in PhRMA v. Concannon out of concern that the Maine Rx program will harm some of Maine's most vulnerable patients -- the frail elderly in the state's nursing homes." Read more |
|